Cargando…
Inhibition of Hepatitis B Virus (HBV) by Tachyplesin, a Marine Antimicrobial Cell-Penetrating Peptide
We investigate the role of Tachyplesin (Tpl), a marine antimicrobial cell-penetrating peptide, as an anti-HBV agent. Our findings, using confocal microscopy and flow cytometry, demonstrate the internalization of FITC-Tpl in both Huh7 and HepG2 cell lines. Further, our results show that Tpl inhibits...
Autores principales: | Narula, Pankhuri, Kiruthika, Sankar, Chowdhari, Shruti, Vivekanandan, Perumal, Chugh, Archana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962029/ https://www.ncbi.nlm.nih.gov/pubmed/36839994 http://dx.doi.org/10.3390/pharmaceutics15020672 |
Ejemplares similares
-
Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties
por: Vernen, Felicitas, et al.
Publicado: (2019) -
Antimicrobial activity of Tachyplesin 1 against Burkholderia pseudomallei: an in vitro and in silico approach
por: Lee, Lyn-Fay, et al.
Publicado: (2016) -
Potential role of the antimicrobial peptide Tachyplesin III against multidrug-resistant P. aeruginosa and A. baumannii coinfection in an animal model
por: Qi, Jialong, et al.
Publicado: (2019) -
A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus
por: Kiruthika, S., et al.
Publicado: (2021) -
Vitamin D signaling inhibits HBV activity by directly targeting the HBV core promoter
por: Ahluwalia, Shivaksh, et al.
Publicado: (2021)